---
figid: PMC4148087__oncotarget-05-4603-g002
figtitle: 'Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer:
  possibilities for therapeutic intervention'
organisms:
- NA
pmcid: PMC4148087
filename: oncotarget-05-4603-g002.jpg
figlink: /pmc/articles/PMC4148087/figure/F2/
number: F2
caption: Sometimes dysregulated expression of growth factor receptors occurs by increased
  expression, genetic translocations or genomic amplifications which can lead to activation
  of the Ras/Raf/MEK/ERK, Ras/PI3K/PTEN/Akt/mTOR and other signaling pathways. Alternatively
  chromosomal translocations can occur in non-receptor kinases and other genes which
  result in activation of these pathways. Genes in the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR
  pathways that have activating mutations detected in human cancer and proliferative
  diseases are indicated in red ovals and squares. Tumor suppressor genes inactivated
  in certain cancer are indicated in black squares or octagons. Other key genes are
  indicated in green ovals. Red arrows indicate activating events in pathways. Blocked
  black arrows indicating inactivating events in pathways.
papertitle: 'Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer:
  possibilities for therapeutic intervention.'
reftext: Nicole M. Davis, et al. Oncotarget. 2014 Jul;5(13):4603-4650.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9044212
figid_alias: PMC4148087__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4148087__F2
ndex: e72c5922-df12-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4148087__oncotarget-05-4603-g002.html
  '@type': Dataset
  description: Sometimes dysregulated expression of growth factor receptors occurs
    by increased expression, genetic translocations or genomic amplifications which
    can lead to activation of the Ras/Raf/MEK/ERK, Ras/PI3K/PTEN/Akt/mTOR and other
    signaling pathways. Alternatively chromosomal translocations can occur in non-receptor
    kinases and other genes which result in activation of these pathways. Genes in
    the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR pathways that have activating mutations
    detected in human cancer and proliferative diseases are indicated in red ovals
    and squares. Tumor suppressor genes inactivated in certain cancer are indicated
    in black squares or octagons. Other key genes are indicated in green ovals. Red
    arrows indicate activating events in pathways. Blocked black arrows indicating
    inactivating events in pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KIT
  - ERBB2
  - PDGFRA
  - GSK3A
  - GSK3B
  - PTEN
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK8
  - MAPK9
  - MAPK10
  - NF1
  - KRAS
  - HRAS
  - NRAS
  - RAF1
  - RNASE3
  - ZHX2
  - ARAF
  - BRAF
  - PHLPP2
  - MAP2K1
  - MAP2K2
  - DUSP4
  - TSC1
  - CCL26
  - MAPK3
  - MAPK1
  - RHEB
  - RHEBP1
  - MTOR
  - RPTOR
  - MAPKAP1
  - RICTOR
  - MLST8
  - NFKB1
  - PA2G4
  - EPHB2
  - IMPG2
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - EIF4B
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - CTNNB1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
